CoChat

Trial of Globus Pallidus Focused Ultrasound Ablation in Parkinson’s Disease

Open access
Krishna, Vibhor, Fishman, Paul S., Eisenberg, Howard M., Kaplitt, Michael, Baltuch, Gordon, Chang, Jin Woo, Chang, Wei-Chieh, Martinez Fernandez, Raul, del Alamo, Marta, Halpern, Casey H., Ghanouni, Pejman, Eleopra, Roberto, Cosgrove, Rees, Guridi, Jorge, Gwinn, Ryder, Khemani, Pravin, Lozano, Andres M., McDannold, Nathan, Fasano, Alfonso, Constantinescu, Marius, Schlesinger, Ilana, Dalvi, Arif, Elias, W. Jeff · 2023 · New England Journal of Medicine
Cited by 163

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Unilateral focused ultrasound ablation of the internal segment of globus pallidus has reduced motor symptoms of Parkinson's disease in open-label studies. METHODS: We randomly assigned, in a 3:1 ratio, patients with Parkinson's disease and dyskinesias or motor fluctuations and motor impairment in the off-medication state to undergo either focused ultrasound ablation opposite the most symptomatic side of the body or a sham procedure. The primary outcome was a response at 3 months, defined as a decrease of at least 3 points from baseline either in the score on the Movement Disorders Society-Unified Parkinson's Disease Rating Scale, part III (MDS-UPDRS III), for the treated side in the off-medication state or in the score on the Unified Dyskinesia Rating Scale (UDysRS) in the on-medication state. Secondary outcomes included changes from baseline to month 3 in the scores on various parts of the MDS-UPDRS. After the 3-month blinded phase, an open-label phase lasted until 12 months. RESULTS: Of 94 patients, 69 were assigned to undergo ultrasound ablation (active treatment) and 25 to undergo the sham procedure (control); 65 patients and 22 patients, respectively, completed the primary-outcome assessment. In the active-treatment group, 45 patients (69%) had a response, as compared with 7 (32%) in the control group (difference, 37 percentage points; 95% confidence interval, 15 to 60; P = 0.003). Of the patients in the active-treatment group who had a response, 19 met the MDS-UPDRS III criterion only, 8 met the UDysRS criterion only, and 18 met both criteria. Results for secondary outcomes were generally in the same direction as those for the primary outcome. Of the 39 patients in the active-treatment group who had had a response at 3 months and who were assessed at 12 months, 30 continued to have a response. Pallidotomy-related adverse events in the active-treatment group included dysarthria, gait disturbance, loss of taste, visual disturbance, and facial weakness. CONCLUSIONS: Unilateral pallidal ultrasound ablation resulted in a higher percentage of patients who had improved motor function or reduced dyskinesia than a sham procedure over a period of 3 months but was associated with adverse events. Longer and larger trials are required to determine the effect and safety of this technique in persons with Parkinson's disease. (Funded by Insightec; ClinicalTrials.gov number, NCT03319485.).

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1056/nejmoa2202721

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 163

Metadata

Authors
Krishna, V., Fishman, P. S., Eisenberg, H. M., Kaplitt, M., Baltuch, G., Chang, J. W., Chang, W.-C., Martinez Fernandez, R., del Alamo, M., Halpern, C. H., Ghanouni, P., Eleopra, R., Cosgrove, R., Guridi, J., Gwinn, R., Khemani, P., Lozano, A. M., McDannold, N., Fasano, A., Constantinescu, M., Schlesinger, I., Dalvi, A., & Elias, W. J.
Venue
New England Journal of Medicine
Published
2023-02-23
Volume
388
Issue
8
Pages
683-693
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W4321480339
Cited by
163
References
2
FWCI
23.96
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Trial of Globus Pallidus Focused Ultrasound Ablation in Parkinson’s Disease. https://app.cochat.ai/papers/10.1056/nejmoa2202721
The paper
Krishna, V., Fishman, P. S., Eisenberg, H. M., Kaplitt, M., Baltuch, G., Chang, J. W., Chang, W.-C., Martinez Fernandez, R., del Alamo, M., Halpern, C. H., Ghanouni, P., Eleopra, R., Cosgrove, R., Guridi, J., Gwinn, R., Khemani, P., Lozano, A. M., McDannold, N., Fasano, A., . . . Elias, W. J. (2023). Trial of Globus Pallidus Focused Ultrasound Ablation in Parkinson’s Disease. New England Journal of Medicine. https://doi.org/10.1056/nejmoa2202721

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.